Search

everythinglearnresearchcommunity

for

Search:↓

Insurance coverage for scalp cooling will make it more accessible to all chemotherapy patients.

Testosterone therapy is effective and safe for women with low sexual desire, but it's hard to access.

Control inflammation and prevent further hair loss in folliculitis decalvans using medications and therapies.

Treating alopecia areata is difficult due to limited approved treatments, but new therapies like JAK inhibitors show promise.

Pediatric dermatologists have varied preferences for treating alopecia areata in children, with no standard FDA-approved treatments and some using JAK inhibitors despite risks.

Low-dose oral minoxidil may help treat hair loss but is not FDA-approved and can cause side effects like unwanted hair growth and heart issues.

Advanced hydrogel systems with therapeutic agents could greatly improve acute and chronic wound treatment.

Lavender is widely used for its calming effects and in beauty products, but its medical effectiveness is not fully proven and not FDA-approved.

The U.S. FDA regulates cosmetics for appearance purposes, but not as strictly as some other countries.

Androgenetic alopecia, a genetic disorder affecting up to 50% of adults, is caused by an excessive response to androgens leading to hair follicle shrinkage. Treatments include FDA-approved drugs, other therapies like low-dose oral minoxidil, and hair transplantation.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

Platelet-rich plasma can increase hair density and may help treat some skin conditions, but it's costly, not FDA-approved, and needs more research.

New treatments for child hair loss due to immune issues are effective but not yet officially approved.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

The document concludes that current hair loss treatments have limitations and suggests researching new treatments targeting different factors of hair loss.

Baricitinib effectively regrows hair in severe alopecia areata cases.

Deoxycholic acid is effective for reducing chin fat but can cause side effects and serious complications, so careful patient evaluation is needed.

A blood pressure drug, diltiazem, may also help treat influenza.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Isotretinoin shows promise as a treatment for Chagas disease by effectively inhibiting key transporters in the parasite.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Minoxidil helps stabilize hair loss, increase density, and reduce shedding after hair transplant surgery.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Various treatments help hair growth, but more research needed for safety and effectiveness.